|
시장보고서
상품코드
1338939
건염 치료 시장 점유율, 규모, 동향, 산업 분석 보고서 : 치료법별, 증상별, 지역별, 부문별 예측(2023-2032년)Tendonitis Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment (Therapy and Surgery); By Condition; By Region; Segment Forecast, 2023-2032 |
||||||
Polaris Market Research의 최신 조사에 따르면, 세계 건염 치료 시장 규모는 2032년까지 2,916억 4,000만 달러에 달할 것으로 예상됩니다. 이 조사 보고서는 현재 시장 역학에 대한 자세한 인사이트와 향후 시장 성장에 대한 분석을 제공합니다.
여러 종류의 스포츠 관련 부상의 증가, 신제품 및 신기술의 끊임없는 혁신, 회복 시간을 단축하고 더 나은 치료 시설을 제공하는 치료법, 그리고 전 세계 정부 기관의 노력 확대는 시장 성장을 촉진하는 주요 요인 중 하나입니다. 또한, 정형외과 수술의 높은 보급률, 확립된 의료 인프라와 치료 시설의 존재, 주요 기업들의 제품 포트폴리오 확대 시행은 세계 시장을 더욱 빠른 속도로 자극할 것으로 보입니다. 예를 들어, 2022년 11월 캠버 제약은 신제품 "Naproxen Oral Suspension"을 추가했습니다. 새로 개발된 이 제품은 건염 증상 치료에 적응증을 가지고 있습니다.
전 세계 환자들은 다운타임을 최소화하고 회복 시간을 단축할 수 있는 비침습적 치료법을 찾고 있으며, 이는 물리치료, 초음파 치료, 충격파 치료와 같은 치료법에 대한 수요를 촉진하고 있습니다. 또한, 힘줄 대체 및 재생 기술의 끊임없는 혁신은 대체 인공 조직에 대한 수요 증가에 대응하여 시장에 긍정적인 영향을 미치고 있습니다. 환자의 혈소판을 환부의 힘줄에 주입하여 조직 회복을 촉진하여 치유를 촉진하는 새로운 종류의 치료법의 보급률이 크게 증가하고 있으며, 이 치료법은 팔꿈치, 어깨, 무릎의 건염 치료에 유망한 치료법으로 전 세계적으로 큰 인기와 견인력을 얻고 있습니다.
이 외에도 의료 기술의 급속한 발전과 함께 약물, 물리치료, 수술 등 다양한 종류의 혁신적인 건염 치료법이 전 세계적으로 사용 가능해지면서 치료의 효과와 효율성이 높아지고 있습니다. 그럼에도 불구하고 조기 진단의 중요성에 대한 인식과 보급이 증가하고 있으며, 이는 시장에 큰 성장 기회를 제공하고 있습니다.
건염 치료 시장 보고서 하이라이트
2022년 시장 점유율은 물리치료 분야가 가장 큰 비중을 차지했는데, 이는 주로 환자를 안심시킬 수 있는 능력과 비용 효율적인 옵션으로 인기를 끌면서 물리치료의 채택이 증가했기 때문입니다.
골퍼 팔꿈치 분야는 사람들의 라이프스타일이 끊임없이 변화하고 스포츠 활동에 대한 관심이 높아지면서 예측 기간 동안 가장 높은 CAGR로 성장할 것으로 예상됩니다.
북미 지역은 사람들의 소비 능력 증가, 잘 정비된 인프라, 의료 기술 기업과의 협업에 대한 높은 보급률로 인해 2022년 세계 시장에서 가장 큰 점유율을 차지할 것으로 예상됩니다.
세계 주요 시장 기업은 Almatica Pharma, Teva Pharmaceuticals Industries, Abbott Laboratories, Stryker Corporation, Ingelheim Pharmaceuticals, Zimmer Biomet Holdings 등입니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 건염 치료 시장에 관한 인사이트
- 건염 치료 시장 - 업계 현황
- 건염 치료 시장 역학
- 성장 촉진요인과 기회
- 스포츠 외상 증가
- 건염 치료 선택사항에 대한 인식 확산
- 성장 억제요인과 과제
- 신흥 국가에서는 보험 적용 범위가 한정되어 있다
- 성장 촉진요인과 기회
- PESTLE 분석
- 건염 치료 업계 동향
- 밸류체인 분석
- COVID-19 감염증의 영향 분석
제5장 세계의 건염 치료 시장, 치료별
- 주요 조사 결과
- 서론
- 치료
- 수술
제6장 세계의 건염 치료 시장, 증상별
- 주요 조사 결과
- 서론
- 테니스엘보
- 골퍼 팔꿈치
- 투수 팔꿈치
- 점퍼 무릎
- 스위머 어깨
- 아킬레스 건염
제7장 세계의 건염 치료 시장, 지역별
- 주요 조사 결과
- 서론
- 건염 치료 시장 평가, 지역별, 2019-2032년
- 건염 치료 시장 - 북미
- 북미 : 건염 치료 시장, 증상별, 2019-2032년
- 북미 : 건염 치료 시장, 치료별, 2019-2032년
- 건염 치료 시장 - 미국
- 건염 치료 시장 - 캐나다
- 건염 치료 시장 - 유럽
- 유럽 : 건염 치료 시장, 증상별, 2019-2032년
- 유럽 : 건염 치료 시장, 치료별, 2019-2032년
- 건염 치료 시장 - 영국
- 건염 치료 시장 - 프랑스
- 건염 치료 시장 - 독일
- 건염 치료 시장 - 이탈리아
- 건염 치료 시장 - 스페인
- 건염 치료 시장 - 네델란드
- 건염 치료 시장 - 러시아
- 건염 치료 시장 - 아시아태평양
- 아시아태평양 : 건염 치료 시장, 증상별, 2019-2032년
- 아시아태평양 : 건염 치료 시장, 치료별, 2019-2032년
- 건염 치료 시장 - 중국
- 건염 치료 시장 - 인도
- 건염 치료 시장 - 말레이시아
- 건염 치료 시장 - 일본
- 건염 치료 시장 - 인도네시아
- 건염 치료 시장 - 한국
- 건염 치료 시장 - 중동 및 아프리카
- 중동 및 아프리카 : 건염 치료 시장, 증상별, 2019-2032년
- 중동 및 아프리카 : 건염 치료 시장, 치료별, 2019-2032년
- 건염 치료 시장 - 사우디아라비아
- 건염 치료 시장 - 아랍에미리트
- 건염 치료 시장 - 이스라엘
- 건염 치료 시장 - 남아프리카공화국
- 건염 치료 시장 - 라틴아메리카
- 라틴아메리카 : 건염 치료 시장, 증상별, 2019-2032년
- 라틴아메리카 : 건염 치료 시장, 치료별, 2019-2032년
- 건염 치료 시장 - 멕시코
- 건염 치료 시장 - 브라질
- 건염 치료 시장 - 아르헨티나
제8장 경쟁 상황
- 확장과 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제9장 기업 개요
- Teva Pharmaceuticals
- Almatica Pharma
- Abbott
- Boehringer Ingelheim
- Bayer
- Merck
- Pfizer
- Teikoku Pharma
- Stryker Corporation
- 3M Company
- Zimmer Biomet
- AKSIGEN
- DJO Global
- AstraZeneca
- GlaxoSmithKline
- Camber Pharmaceuticals
- CoNextions Inc
The global tendonitis treatment market size is expected to reach USD 291.64 billion by 2032, according to a new study by Polaris Market Research. The report "Tendonitis Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment (Therapy and Surgery); By Condition; By Region; Segment Forecast, 2023-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The rising burden of several types of sports-related injuries, constant innovations of new products and technologies, and treatment modalities to offer better treatment facilities with less recovery time, along with the growing efforts undertaken by government organizations worldwide, are among the leading factors driving the market growth. Moreover, the high prevalence of orthopedic procedures, and presence of well-established healthcare infrastructure and treatment facilities, and the implementation of product portfolio expansion by major players, will further stimulate the global market at a significant pace. For instance, in November 2022, Camber Pharmaceuticals added a new product, "Naproxen Oral Suspension." The newly developed product is being indicated to treat the symptoms of tendonitis.
Patients across the globe are increasingly seeking more non-invasive treatment options that offer minimal downtime and faster recovery times, which fuels the demand for therapies such as physical therapy, ultrasound therapy, and shockwave therapy. Additionally, the continuous innovations in tendon replacement and regeneration techniques address the surging demand for alternative engineered tissue and positively influence the market. There has been a significant rise in the penetration for a new kind of treatment, which involves injecting a patient's platelets into the affected tendon to promote healing that can stimulate tissue repair, and the therapy has shown promise in treating tendonitis in the elbow, shoulder, and knee, which is gaining huge popularity and traction all over the world.
Apart from this, with the rapid advances in medical technology, various types of innovative treatment options are available worldwide for tendonitis, including medications, physical therapy, and surgery, which led to increased effectiveness and efficiency of treatment. Despite this, there is an emerging prevalence and awareness regarding the importance of early diagnosis, which creates huge growth opportunities for the market.
Tendonitis Treatment Market Report Highlights
Therapy segment accounted for largest market share in 2022, which is mainly driven by adoption of physical therapy due to its ability to relive patients and its popularity as a cost-efficient option
Golfer's elbow segment is expected to grow at a highest CAGR during the anticipated period, on account of constant changes in people lifestyles and inclination towards sports activity
North America region dominated the global market with maximum share in 2022, owing to increase in people spending capacity, presence of well-developed infrastructure, and high penetration to collaborate with med-tech companies
The global key market players Almatica Pharma, Teva Pharmaceuticals Industries, Abbott Laboratories, Stryker Corporation, Ingelheim Pharmaceuticals, and Zimmer Biomet Holdings
Polaris Market Research has segmented the tendonitis treatment market report based on treatment, condition, and region:
Tendonitis Treatment, Treatment Outlook (Revenue - USD Billion, 2019 - 2032)
- Therapy
- Surgery
Tendonitis Treatment, Condition Outlook (Revenue - USD Billion, 2019 - 2032)
- Tennis Elbow
- Golfer's Elbow
- Pitcher's Elbow
- Jumper's Knee
- Swimmer's Shoulder
- Achille Tendonitis
Tendonitis Treatment, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Tendonitis Treatment Market Insights
- 4.1. Tendonitis Treatment Market - Industry Snapshot
- 4.2. Tendonitis Treatment Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing prevalence of sports injuries
- 4.2.1.2. Growing awareness of tendonitis treatment options
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Insurance coverage is limited in emerging countries
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTLE Analysis
- 4.5. Tendonitis Treatment Industry trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Tendonitis Treatment Market, by Treatment
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Tendonitis Treatment, by Treatment, 2019-2032 (USD Billion)
- 5.3. Therapy
- 5.3.1. Global Tendonitis Treatment Market, by Therapy, by Region, 2019-2032 (USD Billion)
- 5.4. Surgery
- 5.4.1. Global Tendonitis Treatment Market, by Surgery, by Region, 2019-2032 (USD Billion)
6. Global Tendonitis Treatment Market, by Condition
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 6.3. Tennis Elbow
- 6.3.1. Global Tendonitis Treatment Market, by Tennis Elbow, by Region, 2019-2032 (USD Billion)
- 6.4. Golfer's Elbow
- 6.4.1. Global Tendonitis Treatment Market, by Golfer's Elbow, by Region, 2019-2032 (USD Billion)
- 6.5. Pitcher's Elbow
- 6.5.1. Global Tendonitis Treatment Market, by Pitcher's Elbow, by Region, 2019-2032 (USD Billion)
- 6.6. Jumper's Knee
- 6.6.1. Global Tendonitis Treatment Market, by Jumper's Knee, by Region, 2019-2032 (USD Billion)
- 6.7. Swimmer's Shoulder
- 6.7.1. Global Tendonitis Treatment Market, by Swimmer's Shoulder, by Region, 2019-2032 (USD Billion)
- 6.8. Achilles Tendonitis
- 6.8.1. Global Tendonitis Treatment Market, by Achilles Tendonitis, by Region, 2019-2032 (USD Billion)
7. Global Tendonitis Treatment Market, by Geography
- 7.1. Key findings
- 7.2. Introduction
- 7.2.1. Tendonitis Treatment Market Assessment, By Geography, 2019-2032 (USD Billion)
- 7.3. Tendonitis Treatment Market - North America
- 7.3.1. North America: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.3.2. North America: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.3.3. Tendonitis Treatment Market - U.S.
- 7.3.3.1. U.S.: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.3.3.2. U.S.: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.3.4. Tendonitis Treatment Market - Canada
- 7.3.4.1. Canada: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.3.4.2. Canada: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.4. Tendonitis Treatment Market - Europe
- 7.4.1. Europe: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.4.2. Europe: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.4.3. Tendonitis Treatment Market - UK
- 7.4.3.1. UK: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.4.3.2. UK: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.4.4. Tendonitis Treatment Market - France
- 7.4.4.1. France: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.4.4.2. France: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.4.5. Tendonitis Treatment Market - Germany
- 7.4.5.1. Germany: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.4.5.2. Germany: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.4.6. Tendonitis Treatment Market - Italy
- 7.4.6.1. Italy: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.4.6.2. Italy: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.4.7. Tendonitis Treatment Market - Spain
- 7.4.7.1. Spain: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.4.7.2. Spain: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.4.8. Tendonitis Treatment Market - Netherlands
- 7.4.8.1. Netherlands: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.4.8.2. Netherlands: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.4.9. Tendonitis Treatment Market - Russia
- 7.4.9.1. Russia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.4.9.2. Russia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.5. Tendonitis Treatment Market - Asia Pacific
- 7.5.1. Asia Pacific: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.5.2. Asia Pacific: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.5.3. Tendonitis Treatment Market - China
- 7.5.3.1. China: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.5.3.2. China: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.5.4. Tendonitis Treatment Market - India
- 7.5.4.1. India: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.5.4.2. India: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.5.5. Tendonitis Treatment Market - Malaysia
- 7.5.5.1. Malaysia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.5.5.2. Malaysia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.5.6. Tendonitis Treatment Market - Japan
- 7.5.6.1. Japan: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.5.6.2. Japan: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.5.7. Tendonitis Treatment Market - Indonesia
- 7.5.7.1. Indonesia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.5.7.2. Indonesia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.5.8. Tendonitis Treatment Market - South Korea
- 7.5.8.1. South Korea: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.5.8.2. South Korea: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.6. Tendonitis Treatment Market - Middle East & Africa
- 7.6.1. Middle East & Africa: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.6.2. Middle East & Africa: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.6.3. Tendonitis Treatment Market - Saudi Arabia
- 7.6.3.1. Saudi Arabia: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.6.3.2. Saudi Arabia: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.6.4. Tendonitis Treatment Market - UAE
- 7.6.4.1. UAE: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.6.4.2. UAE: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.6.5. Tendonitis Treatment Market - Israel
- 7.6.5.1. Israel: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.6.5.2. Israel: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.6.6. Tendonitis Treatment Market - South Africa
- 7.6.6.1. South Africa: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.6.6.2. South Africa: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.7. Tendonitis Treatment Market - Latin America
- 7.7.1. Latin America: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.7.2. Latin America: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.7.3. Tendonitis Treatment Market - Mexico
- 7.7.3.1. Mexico: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.7.3.2. Mexico: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.7.4. Tendonitis Treatment Market - Brazil
- 7.7.4.1. Brazil: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.7.4.2. Brazil: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
- 7.7.5. Tendonitis Treatment Market - Argentina
- 7.7.5.1. Argentina: Tendonitis Treatment Market, by Condition, 2019-2032 (USD Billion)
- 7.7.5.2. Argentina: Tendonitis Treatment Market, by Treatment, 2019-2032 (USD Billion)
8. Competitive Landscape
- 8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
- 8.2. Partnerships/Collaborations/Agreements/Exhibitions
9. Company Profiles
- 9.1. Teva Pharmaceuticals
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
- 9.2. Almatica Pharma
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
- 9.3. Abbott
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
- 9.4. Boehringer Ingelheim
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
- 9.5. Bayer
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
- 9.6. Merck
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
- 9.7. Pfizer
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
- 9.8. Teikoku Pharma
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
- 9.9. Stryker Corporation
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
- 9.10. 3M Company
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
- 9.11. Zimmer Biomet
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development
- 9.12. AKSIGEN
- 9.12.1. Company Overview
- 9.12.2. Financial Performance
- 9.12.3. Product Benchmarking
- 9.12.4. Recent Development
- 9.13. DJO Global
- 9.13.1. Company Overview
- 9.13.2. Financial Performance
- 9.13.3. Product Benchmarking
- 9.13.4. Recent Development
- 9.14. AstraZeneca
- 9.14.1. Company Overview
- 9.14.2. Financial Performance
- 9.14.3. Product Benchmarking
- 9.14.4. Recent Development
- 9.15. GlaxoSmithKline
- 9.15.1. Company Overview
- 9.15.2. Financial Performance
- 9.15.3. Product Benchmarking
- 9.15.4. Recent Development
- 9.16. Camber Pharmaceuticals
- 9.16.1. Company Overview
- 9.16.2. Financial Performance
- 9.16.3. Product Benchmarking
- 9.16.4. Recent Development
- 9.17. CoNextions Inc
- 9.17.1. Company Overview
- 9.17.2. Financial Performance
- 9.17.3. Product Benchmarking
- 9.17.4. Recent Development
